Clinical Trials for CanariaBio

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CanariaBio

Clinical Trials (4)

NCT05605535
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
PHASE2Active, not recruiting
88 participants
Started: Feb 7, 2023 · Completed: Sep 15, 2027
5 conditions2 sponsors14 locations
NCT05335993
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
PHASE2Active, not recruiting
10 participants
Started: Jul 25, 2022 · Completed: Jul 30, 2025
7 conditions2 sponsors3 locations
NCT04938583
Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
PHASE1/PHASE2Recruiting
54 participants
Started: Mar 17, 2021 · Completed: Dec 31, 2025
3 conditions2 sponsors6 locations
NCT04498117
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
PHASE3Active, not recruiting
615 participants
Started: Aug 25, 2020 · Completed: Aug 26, 2028
10 conditions3 sponsors148 locations